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Antigen-presenting cells, in addition to presenting processed 
antigen, provide co-stimulatory signals that are necessary for 
stimulating maximal lymphokine production by CD4+ T 
cells. For interleukin 2 (IL-2) - producing CD4+ T cells, the 
B7 molecule provides an important co-stimulatory signal 
through interaction with its ligand on the T-cell surface, 
CD28. Populations of antigen-presenting cells that express 
Foreign antigen that penetrates the skin is effectively re-moved by epidermal Langerhans cells, specialized den-dritic cells with a potent capacity for eliciting a T-cell response to that antigen. Once they have captured anti-gen in situ, Langerhans cells leave the epidermis and 
migrate through the afferent lymph or blood stream as veiled cells 
to T -cell- rich regions of draining lymphoid organs. High levels of 
both major histocompatibility complex (MHC) class I and II mole-
cules as well as several cell adhesion molecules, including intercel-
lular adhesion molecule-1 (ICAM-1) and lymphocyte function -
associated antigens (LFA-3), on their surfaces help the dendritic 
cells to efficiently cluster and activate antigen-specific T cells. It has 
been proposed that lymphoid dendritic cells actually serve the dis-
tinct function of initiating a response from quiescent T cells [1]. The 
potency of Langerhans cells as antigen-presenting cells (APC) in 
eliciting a strong T-cell response may help to explain why the skin is 
one of the most sensitive targets for graft versus host disease. 
LANGERHANS CELLS IN ANTIGEN PRESENTATION 
Although they express high levels ofMHC class II products, murine 
Langerhans cells freshly isolated from epidermis are actually poor 
accessory cells, capable only of stimulating a weak primary mixed 
lymphocyte response (MLR) or a weak T-cell mitogenic response to 
anti-CD3 antibody. However, after 1- 3 d of in vitro culture with 
the cytokine granulocyte macrophage/colony-stimulating factor 
(GM-CSF) (added exogenously or produced by contaminating kera-
tinocytes), both mouse [2,3] and human [4,5] Langerhans cells be-
come the most active stimulators of a primary MLR and very effec-
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MHC: major histocompatibility complex 
MLR: mixed lymphocyte reaction 
PBMC: peripheral blood mononuclear cells 
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high levels ofB7 (e.g., dendritic cells) are much more potent 
stimulators of T-cell activation than cells that fail to express 
B7 (e.g., resting B cells). An increase in B7 expression could 
therefore explain the increased accessory function gained by 
Langerhans cells as they leave the skin and migrate to the 
draining lymph node. ] Invest Dermatol 99:62S - 65S, 1992 
tive APC for presenting peptide antigens or mitogenic stimuli that 
do not require processing. Protein antigens, on the other hand, are 
presented more effectively by freshly isolated Langerhans cells, pre-
sumably due to a decreased ability of cultured cells to process and 
present peptides [6]. 
The effects of GM-CSF on cultured Langerhans cells are striking, 
both morphologically and phenotypically. The cells enlarge, de-
velop sheet-like processes (or "veils"), and lose their cytoplasmic 
Birbeck granules, structures whose function is unknown but that 
may playa role in antigen processing. In addition, cultured Langer-
hans cells increase their expression of MHC class I and class II 
molecules severalfold, upregulate adhesion molecules (particularly 
LFA-3), lose their Fcy receptors, and lose expression of the CD1 
antigen, the marker generally used to identify human epidermal 
Langerhans cells. Human Langerhans cells have also been reported 
to exhibit dramatically enhanced expression of RFDA, a marker 
associated with interdigitating cells [5]. Short-term culture of Lan-
gerhans cells, therefore, results in their acquisition of most of the 
features of blood and lymphoid dendritic cells. Blood and lymphoid 
dendritic cells, like cultured Langerhans cells, are potent T-cell 
stimulators [1] . 
The gain in APC function observed when Langerhans cells are 
placed in culture with GM-CSF (considered to be the in vitro equiv-
alent of dendritic cells) is not likely due to upregulation of MHC 
class II, because freshly isolated Langerhans cells express high levels 
of MHC products but are ineffective in stimulating a primary MLR 
or mitogen response. Recent advances in understanding the co-sti-
mulatory signals required of APC, however, may help to explain the 
potent immunostimulatory capacity of Langerhans cells. 
CO-STIMULATORY SIGNALS REQUIRED 
FOR CD4+ T-CELL ACTIVATION 
The recognition of processed antigen/MHC class II complexes on 
the surface of an APC by the clonotypic T-cell receptor (TCR) 
results in a cascade of intracellular signals transduced through the· 
CD3 complex of non-polymorphic proteins associated with the 
TCR (reviewed in [7]). Tyrosine kinase activity occurs within sec-
onds. This is rapidly follo,,",:ed by th~ activation of a phospholipase 
C, which cleaves phosphatldyll11osltol-(1,4)-bisphosphate to pro-
duce inositol trisphosphate and diacylglycerol. These latter two 
molecules induce, respectively, an increase in intracellular calcium 
and the activation of protein kinase C, which are thought to induce 
the synthesis or activation of nuclear factors that then augment 
transcription of lymphokine genes. The combination of a calcium 
ionophore and a protein kinase C-activating phorbol ester mimic 
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TCR occupancy and induce Iymphokine production and T-cell pro-
liferation, providing evidence that th~se two second messengers are 
. d ed causally related to later functional events. 
In llthough the signal resulting from TCR occupancy is necessary 
£ eD4+ helper T-cell activation, it alone is not sufficient to drive ~r T cell to produce IL-2 and subsequently to proliferate (reviewed ~ e[8]). Support for this idea is provided by experiments in which 
In . ne or human IL-2 - producing T -cell clones fail to proliferate 
rnuflroduce IL-2 in response to peptide-pulsed, chemically fixed ~~t~logous resting B cells or I?eriphe~al blood m~monuclear cel ls 
(PBMC), despite the fact they mduce mcreases ~n mtracellul~r cal-
. m in the T cells. This demonstrates that peptide presentatIOn by ~He class II molecules is intact a~d that some o~her APC function 
. ffected. Consistent with tl1lS, viable allogeneic splenocytes that 
15 a ot be recognized by the TCR restore T-cell proliferation and ~~ . dfi I IL-2 production in response to peptide-pulse, xed auto ogous 
APe provided the allogeneic cells are allowed to interact physically 
. th ' the T cells. The provision of the co-stimulatory signal by 
WI essory cells, however, does not augment production of inositol 
a
c
.
c hosphate or diacylglycerol, suggesting that a biochemical path-~;~ distinc.t from inositol phospholipid hydrolysis is involved in 
co_stimulation. 
Similar results have been reported in other cases where !CR 
occupancy occurs in the absence of accessory cells [8) . Imm~blltzed 
tibodies specific for CD3 or the TCR effectively cross-hnk the ~eR/CD3 complex, inducing in T cells the biochemical events 
rmally induced by TCR recognition of peptide/MHC com-
nlexes. Highly purified T-cell clones or freshly isolated T cells fail 
P produce IL-2 under these conditions unless accessory cells are 
:dded. Finally, m~rine T-cell clones f~il to produce IL-2 in response 
to antigenic peptide p.resented by punfied MHC class II molecules 
pported in planar Itpld membranes. In all of these cases, TCR s~cupancy under conditions where co-stimulation is not provided 
o d where T-cell proliferation does not occur results in a long-Iast-~ng state of unresponsiveness (or anergy) to restimulation with 110r-~al APC and antige.n. ~nergy is induce? as a consequence ofTCR-
ediated increases m mtracellular calclUm and can be blocked by ~otein synthesis inhibitors, suggesting that calcium may induce the 
Production of proteins that maintai~ the u~espon.sive state. The 
Presence of viable accessory cells dunng the l11ductlon culture not ~nly allows the T cells to proliferate in response to the TCR stimu-
lus but also allows them to respond normally when rechallenged 
later with APC and antigen. Accessory cells appear to block anergy 
induction indirectly by providing co-stimulatory .signals nece~sary 
for IL-2 production, allowmg the T cells to proltferate ~nd dllu~e 
out or inactivate the anergy prote1l1(s) [9] . The defect 111 anergic 
T-cell clones appears to be at the level ofIL-2 production, although 
T cel ls rendered anergic ill. vivo also display an IL-2 response defect. 
The molecular bases for these defects arc unknown, although defec-
tive signal transduction through the TCR or a repressor protein that 
binds the IL-2 enhailcer and prevents transcription arc possibilities. 
The prevailing view for many ~ear~ has been d~at co-stimulatory 
or "second" signals for T-cell activation are prOVided by IL-l [10] . 
However, many recent studies employing highly purified T cells 
have failed to demonstrate a major role for this cytokine [8) . In fact, 
it has been proposed that IL-1 a.ugment.s T~cell proli~eration.not by 
directly binding to T cell s but l11stead . l~ldlrectly ~y. Improvmg the 
function of accessory cells [11]. In additIOn, dendntlc cells are poor 
IL-1 producers and yet arc the most ~ffe~tive AP~ [12]. Some of ~his 
confusion is clearly related to the dtlfenng co-stuuulatory reqUIre-
ments of various T -cell subsets [13]. For example, for some murine 
IL-4-producing CD4+ T-cell clones, APC-derived IL-1 acts as a 
co-stimulatory molecule by allowing the T cells to respond to the 
IL-4 they produce. 
In contrast, neither IL-l nor any known cytokine provides co-
stimulation to IL-2 - producing T-cell clones or to freshly purified 
T cel ls [8] . Instead an APC surface ligand(s) that must interact with a 
complementary receptor(s) on the T cell is involved. The APC 
ligand(s) appear to be expressed to varying degrees on different APC 
populations. When assayed under conditions where accessory cells 
arc required to provide co-stimulation, but not antigen-presentation 
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(e.g., when purified T cells arc cultured with immobilized anti-
CD3 antibody), dendritic cells are the most potent co-stimulators, 
resting B cells arc weak co-stimulators, and resting T cells do not 
provide co-stimulation at all ([8], JG J and MKJ, unpublished obser-
vation), a hierarchy that mirrors that observed when cells serve as 
APC in an antigen-specific response. Activation of resting B cells 
with lipopolysaccharide or anti-immunoglobulin antibodies plus 
cytokines greatly enhances their co-stimulatory function, indicat-
ing that co-stimulation involves an inducible molecule(s) [13) . 
These results suggest that the level of expression of co-stimulatory 
molecules, and not presentation of ligand to the TCR, may explain 
the observation that APC populations vary with respect to their 
capacity to stimulate CD4+ T cells despite expressing similar levels 
Qf class II MHC. Further support for this idea is provided by the 
finding that low-density splenocytes and resting B cells, popula-
tions that differ greatly with respect to inducing T-cell prolifera-
tion, stimulate similar levels of antigen-induced inositol phosphate 
production by T cells, indicating that they present similar amounts 
of peptide/MHC complexes and that the functional differences 
must be explained by some other effect [14]. 
The observation that the co-stimulatory signal required for maxi-
mal IL-2 production is delivered by T-cell contact w ith APC sug-
gests that adhesion molecule receptor/ligand pairs such as LFA-1/ 
ICAM-l or CD2/LFA-3 might be involved [15] . The observation 
that Langerhans cells upregulate ICAM-l and LFA-3 as they be-
come more potent APC, either in tissue culture or in vivo upon 
entering the lymph or blood stream [1] , is consistent with this possi-
bility. Furthermore, anti-CD2 and anti- LFA-1 monoclonal anti-
bodies can activate T cells under certain conditions. In addition it 
has been reported that T cells respond better to immobilized a~ti­
CD3 antibody if purified ICAM-1 is co-immobilized on the same 
surface, and that alloreactive T-cell clones respond better to human 
leukocyte antigen - DR - transfected murine L cells that express 
ICAM-1 than to those that do not. Similarly, a murine T-cell hybri-
doma transfected with human CD2 responds better to murine APC 
transfected with human LFA-3 than docs the parental CD2 T-cell 
hybridoma. 
Although these phenomena have similarities to the co-stimula-
tory phenomenon described above, there arc important differences. 
The activation caused by anti-CD2 or anti - LFA-1 antibody is asso-
ciated with increases in intracellular calcium [15] , a biochemical 
event that is not associated with delivery of co-stimulatory signals 
[8]. In several early studies [15), optimal enhancement of T-cell 
activation has been observed only when LFA-3 or ICAM-1 were 
presen~ on th~ same surface as the TCR ligand. This finding is 
II1co~slstent Wlt!l the observation that accessory cells can provide 
co-s~llnulatory Signals to T cells stimulated through their TCR via 
peptlde/MHC complexes on the surface of a different fixed APC or 
anti-CD3 antibody on a plate [8). Therefore, it is possible that the 
CD2/LFA-3 and LFA-1 /ICAM-1 pathways enhance T-cell activa-
tion not ?y providing unique co-stimulatory signals but rather by 
augmentmg T -cell/ APC interaction, thus increasing the avidity of 
the TCR and co-stimulatory receptors for their ligands. The recent 
report that ICAM-1 or anti-CD2 antibodies can co-stimulate T cells 
on an independent surface casts some doubt on this conclusion [16). 
In Our opinion, CD28 and its ligand B7 (also known as BB-1) arc 
more likely candidates as the molecules responsible for the co-
sti.l1lulatory pathway described above. CD28 is a 44-kDa glycopro-
tem, a member of the immunoglobulin gene superfamily, and is 
expressed on the majority of human peripheral CD4+ T cells (re-
viewed in [17)). The ligand for CD28 is B7, a 44-54-kDa glyco-
protein that is also a member of the immunoglobulin gene superfa-
mily. B7 is not expressed on resting B cells but is rapidly induced on 
these cells by agents that improve their co-stimulatory function 
(i .e., lipopolysaccharide, Epstein-Barr virus, or anti-surface Ig anti-
body). The functional effects of CD28 stimulation on human T 
cells arc strikingly similar to the effects of accessory cells, as summa-
rized in Table I. The binding of agonistic monoclonal anti-CD28 
antibody alone docs not induce proliferation of purified T cells and 
has no effect onlymphokine production. However, anti-CD28 an-
tibody stimulation augments IYl11phokine production and the prolif-
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Table I. Comparison of the Biologic Activities of Anti-CD28 
Antibody and Accessory Cells 
Activity 
Augment Iymphokine pro-
duction in response to 
TCR stimulation 
Stimulate T-cell proliferation 
in the presence of phorbol 
ester 
Proliferation in the presence 
of phorbol ester is not in-
hibited by cyclosporine 
Action is not dependent on 
inositol phospholipid hy-
drolysis 
Stabilize lymphokine mRNA 
Restore T-cell proliferation 
in response to co-stim-
ulation-deficient APC 
(e.g., pulsed fixed APC) 
Anti-
CD28 
Antibody 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Accessory 
Cells 
Yes 
Yes 
Yes 
Yes 
Yes 
B7 -transfected 
NALM-6 
or CHO cells 
Yes 
Yes 
Yes 
eration of T cells stimulated with suboptimal doses of mitogen, 
antibodies to the TCR/CD3 complex, or anti-CD2 antibody. In 
studies performed with a tetanus toxoid-specific human T -cell line, 
anti-CD28 stimulation also restored T-cell proliferation in response 
to tetanus toxoid-pulsed, fixed APC [18], an effect previously ob-
served only with viable accessory cells. Stimulation of purified 
human T cells with anti-CD28 antibody plus phorbol ester results 
in T-cell proliferation and IL-2 production, by a roorly understood 
mechanism that is independent of accessory cells 17]. In contrast to 
T-cell activation through the TCR/CD3 complex, this response 
occurs with no detectable increase in intracellular calcium and is 
entirely resistant to inhibition by cyclosporine A. Murine T-cell 
clones and purified human T cells also produce IL-2 and proliferate 
in a cyclosporine A - resistant fashion when stimulated with autolo-
gous splenocytes and phorbol ester, suggesting that an APC mole-
cule is capable of stimulating through CD28 [17,18]. CD28 appears 
to exert its effects at the level of Iymphokine production both by 
stabilizing lymphokine mRNA as well as by increasing its rate of 
transcription [17,19]. 
Similarities in the biologic activities of anti-CD28 antibody and 
accessory cells suggest that the effects of stimulating CD28 in vitro 
may be mediated in vivo by its natural ligand on the APC surface. In 
support of this, the level of B7 expressed by a large panel of human 
B-cell tumors correlates closely with the ability of each to stimulate 
a primary MLR and to provide co-stimulatory signals to furified T 
cells stimulated with immobilized anti-CD3 antibody [18 . Further-
more, the transfection ofB7 into a B7 -negative pre-B acute lympho-
blastic leukemia line, NALM-6, confers upon it co-stimulatory func-
tion (JGJ and MKJ, unpublished observations) as evidenced by the 
observations that the B7+ transfectant, but not the parental cell line, 
a) stimulates allogeneic T cells in the MLR; b) stimulates cyclospor-
ine A - resistant T-cell proliferation in the presence of phorbol ester; 
and c) provides co-stimulation to T cells cultured with immobilized 
anti-CD3 antibody. All of the responses stimulated by the B7+ 
transfectant are blocked by anti-B7 antibody, as is the MLR stimu-
lated by B7+ Epstein-Barr Virus-transformed B-cell tumor lines 
[20]. CHO cells transfected with a B7 cDNA also provide co-stim-
ulatory function to purified T cells cultured with anti-CD3 anti-
body immobilized on another surface [21,22]. 
The hierarchy of B7 expression on normal APC populations is 
also consistent with the possibility that this is an important co-stim-
ulatory molecule. Our recent flow-cytometric results show that 
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murine splenic resting B cells, which are poor co-stimulators, ex-
press very little B7; activated B cells, which are intermediate co-
stimulators, express five times more B7 than resting B cells; and 
splenic dendritic cells, which are the most potent co-stimulators, 
express 40 times more B7 than activated B cells (JGJ and MKJ, 
unpublished observations). B7 also appears to be expressed on 
human blood dendritic cells [23]. 
ROLE OF CO-STIMULATORY MOLECULES 
ON APC IN THE SKIN 
The presence ofB7 on an accessory cell confers upon it the ability to 
induce a strong antigen-specific T-cell response. As a result of this 
interaction, the T cell produces increased levels of Iymphokines 
leading to its clonal expansion. In contrast, anergy may result from 
antigen presentation by APC that lack B7. It is tempting to specu-
late that this may explain the recent observations that MHC class 
II -expressing parenchymal cells, including keratinocytes, often fail 
to stimulate CD4+ T cells and instead induce anergy [24,25] . 
Similarly, lack of B7 expression on epidermal Langerhans cells 
may explain the inability of this population to stimulate a primary 
MLR or mitogen response in T cells. B7, however, may be induced 
as Langerhans cells traffic to the lymph node and acquire potent 
accessory functions. This induction may be blocked by ultraviolet 
radiation, explaining the ability of this treatment to destroy the 
co-stimulatory function of Langerhans cells, converting them to 
tolerogenic APC [26]. Conversely, chronic expression of B7 on 
keratinocytes or epidermal Langerhans cells may facilitate the path-
ologic T-cell responses in the skin such as pemphigus or lichen 
planus. These predictions can be tested in the near future as mono-
clonal antibodies specific for murine and human CD28 and B7 
become widely available. 
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